Published in Lancet on February 21, 2004
Host Genetic Susceptibility to Avian Influenza A/H5N1 | NCT01074736
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc Natl Acad Sci U S A (2008) 3.45
Highly pathogenic avian influenza H5N1, Thailand, 2004. Emerg Infect Dis (2005) 3.26
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis (2005) 2.90
Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis (2009) 2.80
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax (2004) 2.78
Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol (2006) 2.77
Pathology of human influenza revisited. Vaccine (2008) 2.71
Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci U S A (2007) 2.67
Monitoring avian influenza A(H7N9) virus through national influenza-like illness surveillance, China. Emerg Infect Dis (2013) 2.61
Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol (2005) 2.51
An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A (2005) 2.33
Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol (2007) 2.30
Risk maps for the spread of highly pathogenic avian influenza in poultry. PLoS Comput Biol (2007) 2.26
Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A (2006) 2.23
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Avian influenza among waterfowl hunters and wildlife professionals. Emerg Infect Dis (2006) 2.05
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother (2007) 2.03
Pandemic influenza threat and preparedness. Emerg Infect Dis (2006) 2.02
Emerging influenza. J Clin Virol (2008) 2.02
Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol (2009) 1.99
The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc (2006) 1.96
Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res (2008) 1.86
Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses. J Virol (2007) 1.86
The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol (2012) 1.84
Unravelling transmission trees of infectious diseases by combining genetic and epidemiological data. Proc Biol Sci (2011) 1.83
Airborne transmission of highly pathogenic H7N1 influenza virus in ferrets. J Virol (2014) 1.82
Characterization of avian H3N3 and H1N1 influenza A viruses isolated from pigs in Canada. J Clin Microbiol (2004) 1.78
Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model. J Virol (2007) 1.76
Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol (2011) 1.74
Structures of receptor complexes of a North American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site. PLoS Pathog (2010) 1.69
Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol (2005) 1.64
A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine. PLoS One (2012) 1.62
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine (2009) 1.56
Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev (2006) 1.52
The transmissibility of highly pathogenic avian influenza in commercial poultry in industrialised countries. PLoS One (2007) 1.51
H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J Virol (2013) 1.48
A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. Virology (2008) 1.48
No evidence of infection with avian influenza viruses among US poultry workers in the Delmarva Peninsula, Maryland and Virginia, USA. J Agromedicine (2011) 1.47
Ocular infection of mice with influenza A (H7) viruses: a site of primary replication and spread to the respiratory tract. J Virol (2009) 1.47
Pandemic influenza and hospital resources. Emerg Infect Dis (2007) 1.44
Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ (2007) 1.43
Physiological-social score (PMEWS) vs. CURB-65 to triage pandemic influenza: a comparative validation study using community-acquired pneumonia as a proxy. BMC Health Serv Res (2007) 1.43
Pathogenicity of highly pathogenic avian influenza virus in mammals. Vaccine (2008) 1.42
Evolutionary analysis of inter-farm transmission dynamics in a highly pathogenic avian influenza epidemic. PLoS Pathog (2011) 1.40
Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Respir Viruses (2009) 1.35
Evidence of infection with H4 and H11 avian influenza viruses among Lebanese chicken growers. PLoS One (2011) 1.35
Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. J Virol (2011) 1.35
Genetics, receptor binding property, and transmissibility in mammals of naturally isolated H9N2 Avian Influenza viruses. PLoS Pathog (2014) 1.33
The animal-human interface and infectious disease in industrial food animal production: rethinking biosecurity and biocontainment. Public Health Rep (2008) 1.30
Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis. J Virol (2013) 1.27
Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness. Clin Vaccine Immunol (2007) 1.27
Detecting emerging transmissibility of avian influenza virus in human households. PLoS Comput Biol (2007) 1.27
Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol (2010) 1.27
Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol (2013) 1.26
Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. J Virol (2014) 1.26
A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J Virol (2010) 1.26
A detailed epidemiological and clinical description of 6 human cases of avian-origin influenza A (H7N9) virus infection in Shanghai. PLoS One (2013) 1.25
Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs. Virol J (2011) 1.25
Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. J Virol (2013) 1.22
Comparative analysis of avian influenza virus diversity in poultry and humans during a highly pathogenic avian influenza A (H7N7) virus outbreak. J Virol (2011) 1.21
H7N9 avian influenza A virus and the perpetual challenge of potential human pandemicity. MBio (2013) 1.20
Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J Clin Microbiol (2010) 1.19
Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus. J Virol (2013) 1.15
Key strategies for reducing spread of avian influenza among commercial poultry holdings: lessons for transmission to humans. Proc Biol Sci (2006) 1.15
The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication. Nat Commun (2014) 1.13
Structure and receptor complexes of the hemagglutinin from a highly pathogenic H7N7 influenza virus. J Virol (2012) 1.13
Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threat. Influenza Other Respir Viruses (2007) 1.12
Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets. J Virol (2008) 1.10
Retracted Targeting pseudoknots in H5N1 hemagglutinin using designed aptamers. Bioinformation (2009) 1.10
Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013. Emerg Infect Dis (2014) 1.09
Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain. J Virol (2009) 1.09
Influenza virus respiratory infection and transmission following ocular inoculation in ferrets. PLoS Pathog (2012) 1.09
Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence. Virol J (2011) 1.08
Evasion of influenza A viruses from innate and adaptive immune responses. Viruses (2012) 1.06
Seroprevalence of avian influenza H9N2 among poultry workers in Shandong Province, China. Eur J Clin Microbiol Infect Dis (2013) 1.05
Industrial food animal production and global health risks: exploring the ecosystems and economics of avian influenza. Ecohealth (2009) 1.03
Neuraminidase and hemagglutinin matching patterns of a highly pathogenic avian and two pandemic H1N1 influenza A viruses. PLoS One (2010) 1.02
A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models. Influenza Other Respir Viruses (2009) 1.01
Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrob Agents Chemother (2008) 1.00
Development and evaluation of a SYBR green-based real time RT-PCR assay for detection of the emerging avian influenza A (H7N9) virus. PLoS One (2013) 1.00
Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines. J Virol (2005) 0.99
Transmission of influenza A viruses. Virology (2015) 0.99
Modelling the wind-borne spread of highly pathogenic avian influenza virus between farms. PLoS One (2012) 0.99
Highly pathogenic avian influenza A(H7N3) virus in poultry workers, Mexico, 2012. Emerg Infect Dis (2013) 0.99
Risk assessment on the epidemics of human infection with a novel avian influenza A (H7N9) virus in Jiangsu Province, China. J Biomed Res (2013) 0.98
Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity. Virol J (2009) 0.97
Epidemiology and management of infectious diseases in international adoptees. Clin Microbiol Rev (2005) 0.96
Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus. PLoS One (2013) 0.96
Epidemiology of the avian influenza A (H7N9) outbreak in Zhejiang Province, China. BMC Infect Dis (2014) 0.96
Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit. Antimicrob Agents Chemother (2014) 0.96
NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J Virol (2010) 0.95
New treatments for influenza. BMC Med (2012) 0.95
Characteristics of human infection with avian influenza viruses and development of new antiviral agents. Acta Pharmacol Sin (2013) 0.94
The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther (2007) 0.93
Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses. J Virol (2014) 0.93
Assessing the role of contact tracing in a suspected H7N2 influenza A outbreak in humans in Wales. BMC Infect Dis (2010) 0.93
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 12.39
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis (2013) 7.83
Avian H5N1 influenza in cats. Science (2004) 5.40
Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet (2004) 5.25
Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med (2013) 5.06
Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis (2009) 4.25
Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol (2007) 3.71
Proposal for a unified norovirus nomenclature and genotyping. Arch Virol (2013) 3.36
A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999. Emerg Infect Dis (2002) 3.24
Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis (2002) 3.24
No association between histo-blood group antigens and susceptibility to clinical infections with genogroup II norovirus. J Infect Dis (2008) 3.04
Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test. J Virol Methods (2005) 2.47
Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl (2008) 2.30
International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses. J Clin Microbiol (2003) 2.23
A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin Infect Dis (2005) 2.20
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol (2010) 2.19
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
Human metapneumovirus in the community. Lancet (2003) 2.07
Influenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe. BMC Infect Dis (2007) 2.06
Etiological role of viruses in outbreaks of acute gastroenteritis in The Netherlands from 1994 through 2005. J Clin Microbiol (2007) 2.02
Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis (2012) 1.90
Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog (2010) 1.88
Automated, laboratory-based system using the Internet for disease outbreak detection, the Netherlands. Emerg Infect Dis (2003) 1.87
Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis (2009) 1.87
Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA (2009) 1.79
Early identification of common-source foodborne virus outbreaks in Europe. Emerg Infect Dis (2003) 1.75
Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics (2011) 1.70
Epidemiology and genotype analysis of emerging sapovirus-associated infections across Europe. J Clin Microbiol (2010) 1.68
[Q fever in 2008 in the Netherlands and the expectations of 2009]. Tijdschr Diergeneeskd (2009) 1.68
Gastroenteritis caused by norovirus GGII.4, The Netherlands, 1994-2005. Emerg Infect Dis (2007) 1.68
Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis (2005) 1.68
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66
Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS One (2012) 1.64
High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J Infect Dis (2008) 1.62
Another phocine distemper outbreak in Europe. Science (2002) 1.55
Norovirus outbreak among primary schoolchildren who had played in a recreational water fountain. J Infect Dis (2004) 1.54
Age-dependent patterns of infection and severity explaining the low impact of 2009 influenza A (H1N1): evidence from serial serologic surveys in the Netherlands. Am J Epidemiol (2011) 1.52
Acute hepatitis B in a healthcare worker: a case report of genuine vaccination failure. J Hepatol (2008) 1.46
Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr (2010) 1.44
Evidence of the etiological predominance of norovirus in gastroenteritis outbreaks--emerging new-variant and recombinant noroviruses in Hungary. J Med Virol (2005) 1.42
Sources of hepatitis E virus genotype 3 in The Netherlands. Emerg Infect Dis (2009) 1.41
Respiratory pathogens in children with and without respiratory symptoms. J Pediatr (2008) 1.40
Seroprotection after hepatitis a vaccination in patients with drug-induced immunosuppression. J Travel Med (2013) 1.39
Too early to stop immigrant vaccination programmes. Eur J Public Health (2009) 1.39
Human Metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev (2011) 1.38
Emergence of new norovirus variants on spring cruise ships and prediction of winter epidemics. Emerg Infect Dis (2008) 1.35
New viruses in idiopathic human diarrhea cases, the Netherlands. Emerg Infect Dis (2014) 1.32
Nosocomial transmission of norovirus is mainly caused by symptomatic cases. Clin Infect Dis (2012) 1.32
Global task force for influenza. Nature (2005) 1.31
Detecting emerging transmissibility of avian influenza virus in human households. PLoS Comput Biol (2007) 1.27
Social-cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men. Prev Med (2005) 1.25
Genetic diversity of noroviruses in raw and treated sewage water. Res Microbiol (2005) 1.22
Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006. BMC Infect Dis (2008) 1.22
Comparative analysis of avian influenza virus diversity in poultry and humans during a highly pathogenic avian influenza A (H7N7) virus outbreak. J Virol (2011) 1.21
Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl (2009) 1.21
Human herpes simplex virus keratitis: the pathogenesis revisited. Ocul Immunol Inflamm (2004) 1.21
Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J Clin Microbiol (2010) 1.19
Feline friend or potential foe? Nature (2006) 1.16
Diagnosis of Norovirus outbreaks by commercial ELISA or RT-PCR. J Virol Methods (2006) 1.14
Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants. Pediatr Allergy Immunol (2003) 1.14
Novel approach for detection of enteric viruses to enable syndrome surveillance of acute viral gastroenteritis. J Clin Microbiol (2009) 1.14
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis (2013) 1.12
Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J Clin Microbiol (2012) 1.12
Towards universal influenza vaccines? Philos Trans R Soc Lond B Biol Sci (2011) 1.12
Using molecular epidemiology to trace transmission of nosocomial norovirus infection. J Clin Microbiol (2010) 1.11
European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus antigen in fecal samples. Clin Vaccine Immunol (2007) 1.11
Preventing pandemics: The fight over flu. Nature (2012) 1.10
Epidemic spread of recombinant noroviruses with four capsid types in Hungary. J Clin Virol (2005) 1.10
Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics (2008) 1.10
September through October 2010 multi-centre study in the Netherlands examining laboratory ability to detect enterovirus 68, an emerging respiratory pathogen. J Virol Methods (2013) 1.10
Detection of noroviruses in shellfish in the Netherlands. Int J Food Microbiol (2006) 1.09
Prevalence of human parechovirus in the Netherlands in 2000 to 2007. J Clin Microbiol (2008) 1.09
Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination. PLoS One (2013) 1.07
Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant. J Clin Virol (2009) 1.07
Use of norovirus genotype profiles to differentiate origins of foodborne outbreaks. Emerg Infect Dis (2010) 1.06
The influence of neonatal lung function on rhinovirus-associated wheeze. Am J Respir Crit Care Med (2010) 1.05
Detection of excess influenza severity: associating respiratory hospitalization and mortality data with reports of influenza-like illness by primary care physicians. Am J Public Health (2010) 1.05
Emerging viral infections in a rapidly changing world. Curr Opin Biotechnol (2003) 1.05
Genetic analysis of the capsid gene of genotype GII.2 noroviruses. J Virol (2008) 1.02
Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? Vaccine (2010) 1.01
Transmission of novel influenza A(H1N1) in households with post-exposure antiviral prophylaxis. PLoS One (2010) 1.01
FAO-OIE-WHO Joint Technical Consultation on Avian Influenza at the Human-Animal Interface. Influenza Other Respir Viruses (2010) 1.01
Respiratory pathogens in respiratory tract illnesses during the first year of life: a birth cohort study. Pediatr Infect Dis J (2009) 0.99
Detection of recombination breakpoints in the genomes of human enterovirus 71 strains isolated in the Netherlands in epidemic and non-epidemic years, 1963-2010. Infect Genet Evol (2011) 0.98
Differential RNA silencing suppression activity of NS1 proteins from different influenza A virus strains. J Gen Virol (2009) 0.97
A mRNA PCR for the diagnosis of feline infectious peritonitis. J Virol Methods (2004) 0.97
Probabilities in norovirus outbreak diagnosis. J Clin Virol (2007) 0.97
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res (2011) 0.97
Highly frequent infections with human rhinovirus in healthy young children: a longitudinal cohort study. J Clin Virol (2011) 0.96
Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine. Vaccine (2007) 0.95
H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates. Vaccine (2011) 0.95
Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study. Pediatrics (2010) 0.95